Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbotulinum Toxin for Periocular Wrinkles
NCT07526870Completed
- Sponsor
- Instituto de Oftalmología Fundación Conde de Valenciana
- Start
- Jul 2024
- Primary completion
- Nov 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in rhytides, sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. Primary endpoint: Change in sebum production at 6 weeks. Started Jul 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on NCT07526870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07526870.